secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neurogene Inc. (NGNE)
CIK:        0001404644
Form:       8-K
Filed at:   2026-07-02T00:02:10+00:00
Accession:  0001404644-26-000050
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neurogene raises ~$134.8M in public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Issued 3.5M shares at $30.00 and pre-funded warrants for 666,666 shares at $29.999999.
- Underwriters exercised option for additional 624,999 shares; total net proceeds ~$134.8M.
- Offering expected to close July 2, 2026; proceeds plus existing cash fund operations into Q1 2029.
- Pre-funded warrants exercisable immediately, subject to 4.99%/9.99% beneficial ownership limitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404644/000140464426000050/0001404644-26-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404644/000140464426000050/ngne-20260630.htm
  HTML page:      https://secwatch.observer/filing/0001404644-26-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer